References
- Sobel JD. Vulvovaginal candidosis. Lancet 2007; 369: 1961–1971.
- Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. Our current understanding of fungal biofilms. Crit Rev Microbiol 2009; 35: 340–355.
- Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. Characterization of mucosal Candida albicans biofilms. PLoS One 2009; 4: e7967. doi:10.1371/journal.pone.0007967.
- Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Jr., Noverr MC. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 2010; 156: 3635–3644.
- Cotter G, Kavanagh K. Adherence mechanisms of Candida albicans. Br J Biomed Sci 2000; 57: 241–249.
- Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 2007; 3: 541–548.
- International Organisation on Standardisation. ISO 4730:2004, Oil of Melaleuca, terpinen-4-ol type (tea tree oil). Geneva, Switzerland: International Organisation for Standardisation, 2004.
- Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50–62.
- Hammer KA, Carson CF, Riley TV. Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans. Med Mycol 2000; 38: 355–362.
- Hammer KA, Carson CF, Riley TV. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae. J Antimicrob Chemother 2004; 53: 1081–1085.
- Vazquez JA, Zawawi AA. Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin Trials 2002; 3: 379–385.
- Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 2003; 51: 1223–1229.
- Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard, 3rd ed, document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
- Altman S, Randers L, Rao G. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 1993; 9: 671–674.
- Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475–2479.
- Jin Y, Samaranayake L, Samaranayake Y, Yip H. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 2004; 49: 789–798.
- Pizzo G, Giuliana G, Milici M, D'Angelo M. Effect of antimicrobial mouthrinses on the in vitro adhesion of Candida albicans to human buccal epithelial cells. Clin Oral Invest 2001; 5: 172–176.
- Colling L, Carter R, Essman M, Larsen B. Evaluation of relative yeast cell surface hydrophobicity measured by flow cytometry. Infect Dis Obstet Gynecol 2000; 13: 43–48.
- Kwiecinski J, Eick S, Wojcik K. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int J Antimicrob Agents 2009; 33: 343–347.
- Brady A, Loughlin R, Gilpin D, Kearney P, Tunney M. In vitro activity of tea-tree oil against clinical skin isolates of meticillin-resistant and -sensitive Staphylococcus aureus and coagulase-negative staphylococci growing planktonically and as biofilms. J Med Microbiol 2006; 55: 1375–1380.
- Dalleau S, Cateau E, Berges T, Berjeaud JM, Imbert C. In vitro activity of terpenes against Candida biofilms. Int J Antimicrob Agents 2008; 31: 572–576.
- Braga PC, Culici M, Alfieri M, Dal Sasso M. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents 2008; 31: 472–477.
- Grubb SE, Murdoch C, Sudbery PE, . Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis. Infect Immun 2008; 76: 4370–4377.
- Li F, Palecek SP. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot Cell 2003; 2: 1266–1273.
- ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, de Groot PW. Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 2009; 88: 105–115.
- Oh KB, Miyazawa H, Naito T, Matsuoka H. Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans. Proc Nat Acad Sci 2001; 98: 4664–4668.
- Hornby JM, Nickerson KW. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob Agents Chemother 2004; 48: 2305–2307.
- Maruyama N, Takizawa T, Ishibashi H, . Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice. Biol Pharm Bull 2008; 31: 1501–1506.